baber/WOPTO huggingface dataset:
Patent FI-904013-A0 (FI)
Inventor: HAAPANEN SAKARI
IPC: H04L7/033
Filed: 1990-08-14
Abstract: PCT No. PCT/FI91/00254 Sec. 371 Date Apr. 5, 1993 Sec. 102(e) Date Apr. 5, 1993 PCT Filed Aug. 14, 1991 PCT Pub. No. WO92/03880 PCT Pub. Date Mar. 5, 1992.A method for compensating a clock's operating error, the method comprising the steps of: producing a clock frequency (f2) from a frequency (f1) of a high-frequency oscillator by dividing it with a constant (K) and; at predetermined times synchronizing the clock to an external reference frequency, characterized in that during the course of clock synchronization, there is measured a clock operating deviation, which is created during a period defined to be a synchronizing interval, by comparing the phase of the clock to that of the reference frequency and, during the synchronizing interval, i.e., the interval between synchronization steps, the oscillator frequency (f1) is adjusted by means of a controlled variable, such as voltage, based on the measurement of an oscillator operating error, in a manner that the effect of the oscillator operating error on the clock frequency is minimized.
Patent FI-912298-A0 (FI)
Inventor: HARTE LAWRENCE J
IPC: H04B1/16
Filed: 1991-05-10
Abstract: Battery power consumption of a cellular telephone is minimized during the stand-by mode by detecting when a received message is intended for another telephone, and for reducing battery power to at least one of the electronic components at the telephone when the transmitted message is intended for another telephone. Power is restored when the next transmitted message is expected to be received by the telephone.   <IMAGE>
Patent FI-913017-A0 (FI)
Inventor: BELL ANDREW SIMON
IPC: A61P9/08
Filed: 1991-06-19
Abstract: Compounds of the formula: <CHEM> wherein R<1> is H, C1-C3 alkyl, C3-C5 cycloalkyl or C1-C3 perfluoroalkyl; R<2> is H, C1-C6 alkyl optionally substituted by OH, C1-C3 alkoxy or C3-C6 cycloalkyl, or C1-C3 perfluoroalkyl; R<3> is C1-C6 alkyl, C3-C6 alkenyl, C3-C6 alkynyl, C3-C7 cycloalkyl, C1-C6 perfluoroalkyl or (C3-C6 cycloalkyl)C1-C6 alkyl; R<4> taken together with the nitrogen atom to which it is attached completes a pyrrolidinyl, piperidino, morpholino, or 4-N-(R<6>)-piperazinyl group; R<5> is H, C1-C4 alkyl, C1-C3 alkoxy, NR<7>R<8>, or CONR<7>R<8>; R<6> is H, C1-C6 alkyl, (C1-C3 alkoxy) C2-C6 alkyl, hydroxy C2-C6 alkyl, (R<7>R<8>N)C2-C6 alkyl, (R<7>R<8>NCO)C1-C6 alkyl, CONR<7>R<8>, CSNR<7>R<8> or C(NH)NR<7>R<8>; R<7> and R<8> are each independently H, C1-C4 alkyl, (C1-C3 alkoxy)C2-C4 alkyl or hydroxy C2-C4 alkyl; and pharmaceutically acceptable salts thereof, are selective cGMP PDE inhibitors useful in the treatment of cardiovascular disorders such as angina, hypertension, heart failure and atherosclerosis.
Patent FI-934711-A0 (FI)
Inventor: MERCIADEZ MEL
IPC: A23L27/30
Filed: 1993-10-25
Abstract: Stabilized aqueous solutions containing sorbic acid or salt thereof in an antimicrobial proportion, and further containing from 0.1, and preferably from 0.2, to about 5 ppm of manganous ion, said manganous ion being in an amount sufficient to inhibit oxidation of said sorbic acid or salt thereof to oxidative products such as acetaldehyde.
Patent FI-946039-A0 (FI)
Inventor: WEICHERT ANDREAS
IPC: C07C233/65
Filed: 1994-12-22
Abstract: There are described acylguanidines I <IMAGE> where X is carbonyl or sulphonyl; R(1) is H, (cyclo)alkyl, phenyl; R(2) is H, alkyl, and their pharmaceutically tolerable salts. They are obtained by reaction of a compound II <IMAGE>  with guanidine. The compounds have no undesired salidiuretic properties, but have very good antiarrhythmic properties. As a result of inhibition of the cellular Na<+>/H<+> exchange mechanism, they can be used for the treatment of all acute or chronic injuries induced by ischaemia.
Patent FI-974651-A0 (FI)
Inventor: ALA-LUUKKO SAMI
IPC: H04W4/24
Filed: 1997-12-31
Abstract: In the inventive system, a telecommunication network includes a calling subscriber's terminal equipment, a called subscriber's terminal equipment, a home location register of the calling subscriber's subscription, a home location register of the called subscriber's subscription, a calling subscriber's visited mobile switching center, a communication server for route optimization of the connection to be set up, and a mobile switching center under which the called subscriber is located. A telecommunication connection is set up from the visited mobile switching center to the mobile switching center on the basis of call pricing data and/or network configuration data. The call pricing data and/or network configuration data for a variety of different possible routes are identified or determined by means of the communication server and used to identify the optimum route for the telecommunication connection.
Patent IL-63398-A0 (IL)
Title: Ultrafiltration membrane and its production
IPC: C08J9/28
Filed: 1981-07-23
Abstract: A membrane is disclosed of polyamide, a copolyamide or a mixture of polyamides, suitable for ultrafiltration and composed of an ultrafiltration skin and a backing layer. The pore size in the backing layer increases with distance from the ultrafiltration skin. The membrane is prepared by dissolving a polyamide in at least 75% formic acid, applying a casting solution, containing about 12-22% by weight polyamide and about 1-7% by weight polyethylene glycol in formic acid which has been brought to a temperature of below about 18 DEG  C., as a thin layer onto a carrier foil resistant to the components of the solution, introducing the casting solution on the carrier foil into a precipitation and washing bath, withdrawing the casting solution as a coagulated and washed membrane from the carrier foil, stretching in at least one direction and subsequently drying this coagulated and washed membrane.
Patent IL-75074-A0 (IL)
Title: Improvements in circular knitting machines
IPC: D04B25/02
Filed: 1985-05-02
Abstract: 1. A circular knitting machine with a set of tongued needles that are located around a cylinder, and with a drive, characterized in that the cylinder (5) is movable vertically upwards and downwards by the drive, whilst the set of needles (2) remains stationary.
Patent IL-80020-A0 (IL)
Title: Antibody complexes of hapten-modified diagnostic or therapeutic agents
IPC: A61K39/385
Filed: 1986-09-12
Abstract: Antibody complexes comprising hapten-modified diagnostic or therapeutic agents and anti-hapten antibodies are disclosed. Administration of hapten-modified agents, complexed with suitable anti-hapten antibodies, extends the serum half-life and permits an increased concentration of such diagnostic or therapeutic agents at in vivo target sites.
Patent IL-80558-A0 (IL)
Title: Cephalosporin derivatives and process for their preparation
IPC: A61K/
Filed: 1986-11-10
Abstract: Cephalosporin derivatives of the formula <IMAGE> pharmaceutical preparations active against bacterial infections and which contain such cephem derivatives, process for the production of the pharmaceutical preparations and use of the cephem derivatives for combating bacterial infections.
Patent IL-80765-A0 (IL)
Title: Desensitization to corrosion of a1 alloys containing li
IPC: C22F1/04
Filed: 1986-11-26
Abstract: 1. A process for the heat treatment of Al alloys containing Li to improve their resistance to exfoliation corrosion while retaining a high level of mechanical strength and good resistance to damage characterised in that the final ageing operation is carried out in the following range of temperatures T (in degree C) and times t (in hours) : t >= 24 X 5 exp ((150-T)/30) t =< 80 X 5 exp ((150-T)/30) with : T =< 160 degrees C for Mg >= 2% T =< 160 degrees C-5 (2-% Mg) degrees C for 1 =< Mg =< 2% T =< 155 degrees C for Mg =< 1%.
Patent IL-81335-A0 (IL)
Title: Imidazo(1,2-a)quinoline derivatives,their preparation and their application in therapy
IPC: A61P25/08
Filed: 1987-01-21
Abstract: 1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Imidazo[1,2-_a]quinoline derivatives corresponding to the formula (I)  see diagramm : EP0233800,P14,F1  in which X denotes hydrogen, a halogen or a (C1-4 )alkyl, (C1-4 )-alkoxy, (C1-4 )alkylthio, methylsulphonyl, amino, (C1-4 )-alkylamino, di(C1-4 )alkylamino, nitro or trifluoroalkyl group, Y denotes hydrogen, a halogen or a methyl group at position 6, 7 or 8, and R1 and R2, taken separately, each denote hydrogen or a (C1-6 )alkyl group, or alternatively R1 and R2 together form a tetramethylene, pentamethylene, 3-methyl-3-azapentamethylene or 3-oxapentamethylene chain, as well as their addition salts which are acceptable in pharmacology. 1. Claims for the Contracting States : AT, ES, GR Process for the preparation of imidazo[1,2-_a]quinoline derivatives corresponding to the formula (I)  see diagramm : EP0233800,P16,F1  in which X denotes hydrogen, a halogen or a (C1-4 )alkyl, (C1-4 )-alkoxy, (C1-4 )alkylthio, methylsulphonyl, amino, (C1-4 )-alkylamino, di(C1-4 )alkylamino, nitro or trifluoroalkyl group, Y denotes hydrogen, a halogen or a methyl group at position 6, 7 or 8, and R1 and R2, taken separately, each denote hydrogen or a (C1-6 )alkyl group, or alternatively R1 and R2 together form a tetramethylene, pentamethylene, 3-methyl-3-azapentamethylene or 3-oxapentamethylene chain, which process is characterized in that the quinoline of formula (II)  see diagramm : EP0233800,P16,F2  is first subjected to the action of an alpha-bromoacetophenone bearing the substituent X defined above, in the heated state in a solvent such as methylene chloride or 1,2-dichloroethane ; an ionic compound of formula (III)  see diagramm : EP0233800,P16,F3  is obtained, which is cyclized in the presence of ammonium acetate, in an acidic organic solvent such as acetic or propionic acid, at a temperature of 90 degrees C, to obtain the compound of formula (IV)  see diagramm : EP0233800,P16,F4  the compound obtained (IV) is reacted with glyoxylic acid in a solvent such as acetic acid at 80 degrees C ; the alpha-hydroxy acid obtained (V)  see diagramm : EP0233800,P17,F1  is acetylated using acetic anhydride in the presence of pyridine, and then converted to the alpha-acetoxyacetamide  see diagramm : EP0233800,P17,F2  via the imidazolide, which is prepared in situ ; the compound (VI) is deacetylated to the alpha-hydroxyacetamide (VII) see diagramm : EP0233800,P17,F3  by treatment with potassium carbonate in ethanol ; the compound (VII) is reacted with sulphonyl chloride SOCl2 in a chlorinated solvent such as dichloromethane, to obtain the chlorinated compound (VIII)  see diagramm : EP0233800,P17,F4  which is reduced using Rongalite**(r) in methylene chloride to the compound (I).
Patent IL-83153-A0 (IL)
Title: Substituted imidazoles,their preparation and pharmaceutical compositions containing them
IPC: A61K31/4174
Filed: 1987-07-10
Abstract: Substituted imidazoles such as <CHEM> are useful as angiotensin II blockers. These compounds have activity in treating hypertension and congestive heart failure.
Patent AU-PO598797-A0 (AU)
Title: Mops
IPC: A47L13/258
Filed: 1997-04-04
Abstract: A mop is provided which has an elongate handle (3), a mop head (5), for carrying a squeezable mop material (13). The mop has arms (27, 29, 37, 39) which can be moved to effect squeezing of the mop material (13). The mop has a two axis swivel connector (7) which has two mutually perpendicular axis (57 and 59). The arrangement is such that the mop head (5) can be swung to various angular orientations relative to the handle (3) at the same time. A stop (56) is provided on the mop head (5) to act with the handle (3) when the arms (27, 29, 37, 39) are moved to effect squeezing, thereby allowing a squeezing force to be applied to the mop material (13).
Patent FI-20001857-A0 (FI)
Inventor: LEHTONEN VEERA
IPC: H04L9/32
Filed: 2000-08-22
Abstract: A method for the replacement of a certificate with a new certificate, when the certificate granted to the owner is cancelled or the certificate is expired. In the method a signed certificate message is received, data from the said certificate is stored and the said certificate is verified before the storage of it. In accordance with the invention, before the storage of the certificate, the earlier identity in said signed certificate is compared with the identity concerned with the certificate in use. If the identities match, the certificate concerned with said earlier identity is removed from the group of trusted certificates; and the new certificate indicated in said certificate message by the new identity is added to the group of trusted certificates.
Patent IL-104960-A0 (IL)
Title: 4-oxo-2-thioxoimidazolidine derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D233/54
Filed: 1993-03-05
Abstract: 4-oxo-2-thioxoimidazolidine derivates have the general formula (I), in which R?1 to R?4 and Y have the definition given in the description. Also disclosed is a process for preparing these derivates and their use as inhibitors of thrombocyte aggregation, of the formation of carcinoma cell metastases and of the binding of osteoclalsts to bone surfaces.
Patent IL-105011-A0 (IL)
Title: Physiologically active substances of plant,process for the preparation thereof,and utilities thereof
IPC: C07H15/18
Filed: 1993-03-11
Abstract: A compound represented by the formula (I) <CHEM> wherein R<1>, R<2>, R<3>, R<4>, and R<5> each independently represents hydrogen, acetyl or benzyl, R<6> represents hydrogen, hydroxyl, acetoxy, or benzyloxy, R<7> represents hydrogen, or R<6> and R<7> together represent a direct bond, and R<8> represents carboxyl, methoxycarbonyl, hydroxymethyl, or acetoxymethyl; or a salt thereof. The compound is useful for plant culture, growth inhibition of moyashi roots, and growth promotion of moyashi hypocotyls.
Patent IL-118155-A0 (IL)
Title: Method and hardware for handling and processing of a plurality of liquid specimens
IPC: B01L3/00
Filed: 1996-05-06
Abstract: An apparatus for use with an array of liquid specimen containers having open upper ends includes a panel structure having an array of openings corresponding to the array of liquid specimen containers such that the open upper ends of the containers will be aligned with the openings upon placement of the panel structure over the containers in an upright engagement with the containers. The apparatus further includes filter material stretched across the openings so as to extend across the open upper ends of the containers in overlying abutment with the open upper ends of the containers when the panel structure is in the upright engagement. In this arrangement, liquid contents of the containers can flow downward through the filter material when the panel structure and the containers are together moved from their upright engagement to an overturned engagement inverted from their upright engagement.
Patent IL-125330-A0 (IL)
Title: Method of matching tissue for transplantation
IPC: G01N33/531
Filed: 1998-07-13
Abstract: The present invention relates to an improved method and kit for the detection of antibodies directed against the human immunodeficiency virus (HIV) in whole blood obtained from individuals who are HIV-seronegative as determined by conventional assay techniques. Whole blood is isolated from these individuals and cultured directly with mitogen to stimulate the proliferation of B-lymphocytes producing immunoglobulin specific for HIV. This method provides a rapid, simple, and inexpensive means for screening large numbers of blood samples for HIV infection while minimizing exposure of the technician to infectious blood components.
Patent IL-134985-A0 (IL)
Title: A method for contrast enhanced diagnostic imaging
IPC: G01R33/48
Filed: 1998-09-24
Abstract: The present invention relates to a contrast-enhanced diagnostic imaging method for monitoring the efficacy of interventional therapies. The contrast agents useful in this method comprise an image-enhancing moiety (IEM) and a state-dependent tissue binding moiety (SDTBM). These contrast agents exhibit state-dependent binding to one or more components of a targeted tissue or tissue component and provide a detectable change in the signal characteristics of the agent once bound to the targeted tissue. As a result, these agents exhibit a binding affinity for, and thus image contrast of, the targeted tissue which changes as the tissue-state changes during therapy.
Patent IL-136526-A0 (IL)
Title: Ice cube bag and a method of producing ice cube bags
IPC: F25C1/24
Filed: 1998-12-09
Abstract: An ice cube bag comprises two sheet-shaped foil layers (12, 14; 12', 14') defining an outer periphery. A peripheral joint (20, 21, 21a, 21b) extends along the major part of the outer periphery of the foil layers, with the exception of a peripheral area constituting a inlet aperture of said bag (10). Their peripheral joint joins the foil layers together defining an inner chamber which is divided into several ice cube compartments defined by separate joints (22, 23, 24, 25, 29) of the foil layers. An inlet channel extends from the inlet aperture to the inner chamber of the bag hereby allowing admission from the surroundings to the inner chamber of the bag through the inlet channel. Each of said separate joints (22, 23, 24, 25, 29) is constituted by a number of individual joints (22, 23, 24, 25, 29), each of these individual joints (22, 23, 24, 25, 29) establishing a connection between the two sheet-shaped foil layers (12, 14; 12', 14') with such a joint strength and with such a limited area extension that the individual joint is not broken when the foil layers (12, 12; 12', 14') are exposed to a separation force, but provides a tearing apart or perforation (44) in one of the foil layers (12, 14; 12', 14') along the periphery of said individual joints. Hereby an ice cube bag is obtained which is easy to open by tearing it apart. <IMAGE>   <IMAGE>   <IMAGE>
Patent IL-136898-A0 (IL)
Title: Microparticles and their therapeutic or diagnostic use
IPC: A61K38/21
Filed: 1998-12-21
Abstract: Microcapsules having a wall thickness of no more than 500 nm, and a bulk density of no more than 0.2 g.cm-3, are suitable for therapeutic or diagnostic use. They are aerodynamically light, and can be used for delivery to the lung, or diagnosis by ultrasound.
Patent IL-142496-A0 (IL)
Title: N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
IPC: A61P29/00
Filed: 1999-10-14
Abstract: The compounds of formula 1 wherein R and R<SUB>2 </SUB>are as defined in the disclosure, are useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.
Patent IL-144129-A0 (IL)
Title: Methods and kits for sequencing polypeptides
IPC: C07K1/12
Filed: 2000-01-12
Abstract: The present disclosure provides methods and kits which are useful for sequencing polypeptides. The methods involve derivatization of the N-terminus of the polypeptide or peptides thereof. Mass spectral analysis of one or more of the resulting derivatized analytes provides spectra which are readily interpreted through the use of techniques well-known to the ordinarily skilled artisan. The present disclosure also describes kits which enhance convenient performance of the methods.
Patent IL-148631-A0 (IL)
Title: Quinuclidine derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
IPC: A61P43/00
Filed: 2000-09-27
Abstract: The present invention provides an excellent squalene synthesizing enzyme inhibitor. Specifically, it provides a compound (I) represented by the following formula, a salt thereof or a hydrate of them. <CHEM> In which R<1> represents (1) hydrogen atom or (2) hydroxyl group; HAr represents an aromatic heterocycle which may be substituted with 1 to 3 groups; Ar represents an optionally substituted aromatic ring; W represents a chain represented by (1) -CH2-CH2- which may be substituted, (2) -CH=CH- which may be substituted, (3) -C IDENTICAL C-, (4) -NH-CO-, (5) -CO-NH-, (6) -NH-CH2-, (7) -CH2-NH-, (8) -CH2-CO-, (9) -CO-CH2- (10) -NH-S(O)1-, (11) -S(O)1-NH-, (12) -CH2-S(O)1- or (13) -S(O)1-CH2- (1 denotes 0, 1 or 2); and X represents a chain represented by (1) a single bond, (2) an optionally substituted C1-6 alkylene chain, (3) an optionally substituted C2-6 alkenylene chain, (4) an optionally substituted C2-6 alkynylene chain, (5) a formula -Q- (wherein Q represents oxygen atom, sulfur atom, CO or N(R<2>) (wherein R<2> represents a C1-6 alkyl group or a C1-6 alkoxy group)), (6) -NH-CO-, (7) -CO-NH-, (8) -NH-CH2-, (9) -CH2-NH-, (10) -CH2-CO-, (11) -CO-CH2-, (12) -NH-S(O)m-, (13) -S(O)m-NH-, (14) -CH2-S(O)m-, (15) - S(O)m-CH2- (wherein m denotes 0, 1 or 2) or (16) -(CH2)n-O- (wherein n denotes an integer from 1 to 6).
Patent IL-152590-A0 (IL)
Title: Treatment of congestive heart failure
IPC: A61P9/00
Filed: 2001-03-22
Abstract: Combinations of diuretics and vasopressin antagonists are useful to slow and reverse the symptoms and process of congestive heart failure, to increase the excretion of water in the urine, and to decrease the excretion of sodium and potassium ions in urine. Preferred vasopressin antagonists have the formula (I) wherein R and R<5> are hydrogen or lower alkyl; R<1>, R<2>, and R<3> are hydrogen, halo, alkyl, alkoxy, and amino; and R<4> is hydrogen or phenyl, and a pharmaceutically acceptable salt thereof.
Patent IL-156322-A0 (IL)
Title: Wideband dual amplifier circuits
IPC: H03F3/193
Filed: 2001-12-19
Abstract: Dual amplifying circuits having a magnetic tunnel junction device and a field effect transistor configured in a complementing set are disclosed herein. In one embodiment, the field effect transistor is operable to control a current level of a current operating signal flowing through the magnetic tunnel junction device. In another embodiment, the magnetic tunnel junction device is operable to control a voltage level of a voltage signal being applied to a gate terminal of the field effect transistor. The gain-bandwidth product of both embodiments is greater than the individual gain-bandwidth products of the individual devices through the elimination of noise contributing resistive type circuit elements.
Patent IL-176596-A0 (IL)
Title: Modified human interferon polypeptides and their uses
IPC: A61K38/21
Filed: 2006-06-28
Abstract: Modified human growth hormone polypeptides and uses thereof are provided.
Patent IL-179016-A0 (IL)
Title: Compressed tablet comprising valsarta
IPC: A61K31/4188
Filed: 2006-11-02
Abstract: The invention relates to the use of an AT 1  receptor antagonist or or an AT 2  receptor modulator, respectively, or a pharmaceutically acceptable salt thereof, for producing a pharmaceutical preparation for the treatment of conditions or diseases associated with the increase of AT 1  receptors in the sub-epithelial area or increase of AT 2  receptors in the epithelia.
Patent IL-192949-A0 (IL)
Title: Kinase inhibitors and methods of use thereof
Filed: 2008-07-22
Abstract: The compound of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof are useful in the treatment and prevention of various disorders mediated by kinases.